PATENT CLAIM ANALYSIS

Application Number: 16244427
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "451000"]

Abstract:
The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.

Claim (Index 1):
A method of inhibiting or suppressing metastasis of pancreatic cancer in a human subject comprising administering cysteamine, cystamine or a pharmaceutically acceptable salt thereof to the subject in an amount effective to inhibit metastasis of the cancer, but less than an amount cytotoxic to the cancer, and wherein the cysteamine, cystamine or pharmaceutically acceptable salt thereof is administered at a daily dose of at least 10 mg/kg.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.55556
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14353273', '14332829', '13277942', '15284416', '15771947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7281227972111548
- 35 USC 102 Novelty (BERT): 0.5002276810089804
- Combined Prediction Score: 0.7053332855909373
- Mean Citation Score: 249.429072
- Max Citation Score: 254.49219
- Similarity Product: 183.56094051728007

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test